2llp

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
==Solution structure of a THP type 1 alpha 1 collagen fragment (772-786)==
==Solution structure of a THP type 1 alpha 1 collagen fragment (772-786)==
-
<StructureSection load='2llp' size='340' side='right'caption='[[2llp]], [[NMR_Ensembles_of_Models | 30 NMR models]]' scene=''>
+
<StructureSection load='2llp' size='340' side='right'caption='[[2llp]]' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[2llp]] is a 3 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2LLP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2LLP FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[2llp]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2LLP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2LLP FirstGlance]. <br>
-
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2llp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2llp OCA], [https://pdbe.org/2llp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2llp RCSB], [https://www.ebi.ac.uk/pdbsum/2llp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2llp ProSAT]</span></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2llp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2llp OCA], [https://pdbe.org/2llp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2llp RCSB], [https://www.ebi.ac.uk/pdbsum/2llp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2llp ProSAT]</span></td></tr>
</table>
</table>
== Disease ==
== Disease ==
-
[[https://www.uniprot.org/uniprot/CO1A1_HUMAN CO1A1_HUMAN]] Defects in COL1A1 are the cause of Caffey disease (CAFFD) [MIM:[https://omim.org/entry/114000 114000]]; also known as infantile cortical hyperostosis. Caffey disease is characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref> <ref>PMID:15864348</ref> Defects in COL1A1 are a cause of Ehlers-Danlos syndrome type 1 (EDS1) [MIM:[https://omim.org/entry/130000 130000]]; also known as Ehlers-Danlos syndrome gravis. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS1 is the severe form of classic Ehlers-Danlos syndrome.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref> <ref>PMID:10739762</ref> <ref>PMID:17211858</ref> Defects in COL1A1 are the cause of Ehlers-Danlos syndrome type 7A (EDS7A) [MIM:[https://omim.org/entry/130060 130060]]; also known as autosomal dominant Ehlers-Danlos syndrome type VII. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS7A is marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref> Defects in COL1A1 are a cause of osteogenesis imperfecta type 1 (OI1) [MIM:[https://omim.org/entry/166200 166200]]. A dominantly inherited connective tissue disorder characterized by bone fragility and blue sclerae. Osteogenesis imperfecta type 1 is non-deforming with normal height or mild short stature, and no dentinogenesis imperfecta.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref> <ref>PMID:3244312</ref> <ref>PMID:2794057</ref> <ref>PMID:1718984</ref> <ref>PMID:1634225</ref> <ref>PMID:1737847</ref> <ref>PMID:8223589</ref> <ref>PMID:16705691</ref> <ref>PMID:16786509</ref> <ref>PMID:16638323</ref> <ref>PMID:17875077</ref> <ref>PMID:18670065</ref> Defects in COL1A1 are a cause of osteogenesis imperfecta type 2 (OI2) [MIM:[https://omim.org/entry/166210 166210]]; also known as osteogenesis imperfecta congenita. A connective tissue disorder characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. Defects in COL1A1 are a cause of osteogenesis imperfecta type 3 (OI3) [MIM:[https://omim.org/entry/259420 259420]]. A connective tissue disorder characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera, and dentinogenesis imperfecta. Defects in COL1A1 are a cause of osteogenesis imperfecta type 4 (OI4) [MIM:[https://omim.org/entry/166220 166220]]; also known as osteogenesis imperfecta with normal sclerae. A connective tissue disorder characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. Genetic variations in COL1A1 are a cause of susceptibility to osteoporosis (OSTEOP) [MIM:[https://omim.org/entry/166710 166710]]; also known as involutional or senile osteoporosis or postmenopausal osteoporosis. Osteoporosis is characterized by reduced bone mass, disruption of bone microarchitecture without alteration in the composition of bone. Osteoporotic bones are more at risk of fracture.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref> <ref>PMID:8841196</ref> <ref>PMID:9535665</ref> Note=A chromosomal aberration involving COL1A1 is found in dermatofibrosarcoma protuberans. Translocation t(17;22)(q22;q13) with PDGF.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref>
+
[https://www.uniprot.org/uniprot/CO1A1_HUMAN CO1A1_HUMAN] Defects in COL1A1 are the cause of Caffey disease (CAFFD) [MIM:[https://omim.org/entry/114000 114000]; also known as infantile cortical hyperostosis. Caffey disease is characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref> <ref>PMID:15864348</ref> Defects in COL1A1 are a cause of Ehlers-Danlos syndrome type 1 (EDS1) [MIM:[https://omim.org/entry/130000 130000]; also known as Ehlers-Danlos syndrome gravis. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS1 is the severe form of classic Ehlers-Danlos syndrome.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref> <ref>PMID:10739762</ref> <ref>PMID:17211858</ref> Defects in COL1A1 are the cause of Ehlers-Danlos syndrome type 7A (EDS7A) [MIM:[https://omim.org/entry/130060 130060]; also known as autosomal dominant Ehlers-Danlos syndrome type VII. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS7A is marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref> Defects in COL1A1 are a cause of osteogenesis imperfecta type 1 (OI1) [MIM:[https://omim.org/entry/166200 166200]. A dominantly inherited connective tissue disorder characterized by bone fragility and blue sclerae. Osteogenesis imperfecta type 1 is non-deforming with normal height or mild short stature, and no dentinogenesis imperfecta.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref> <ref>PMID:3244312</ref> <ref>PMID:2794057</ref> <ref>PMID:1718984</ref> <ref>PMID:1634225</ref> <ref>PMID:1737847</ref> <ref>PMID:8223589</ref> <ref>PMID:16705691</ref> <ref>PMID:16786509</ref> <ref>PMID:16638323</ref> <ref>PMID:17875077</ref> <ref>PMID:18670065</ref> Defects in COL1A1 are a cause of osteogenesis imperfecta type 2 (OI2) [MIM:[https://omim.org/entry/166210 166210]; also known as osteogenesis imperfecta congenita. A connective tissue disorder characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. Defects in COL1A1 are a cause of osteogenesis imperfecta type 3 (OI3) [MIM:[https://omim.org/entry/259420 259420]. A connective tissue disorder characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera, and dentinogenesis imperfecta. Defects in COL1A1 are a cause of osteogenesis imperfecta type 4 (OI4) [MIM:[https://omim.org/entry/166220 166220]; also known as osteogenesis imperfecta with normal sclerae. A connective tissue disorder characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. Genetic variations in COL1A1 are a cause of susceptibility to osteoporosis (OSTEOP) [MIM:[https://omim.org/entry/166710 166710]; also known as involutional or senile osteoporosis or postmenopausal osteoporosis. Osteoporosis is characterized by reduced bone mass, disruption of bone microarchitecture without alteration in the composition of bone. Osteoporotic bones are more at risk of fracture.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref> <ref>PMID:8841196</ref> <ref>PMID:9535665</ref> Note=A chromosomal aberration involving COL1A1 is found in dermatofibrosarcoma protuberans. Translocation t(17;22)(q22;q13) with PDGF.<ref>PMID:8988177</ref> <ref>PMID:12660034</ref>
== Function ==
== Function ==
-
[[https://www.uniprot.org/uniprot/CO1A1_HUMAN CO1A1_HUMAN]] Type I collagen is a member of group I collagen (fibrillar forming collagen).
+
[https://www.uniprot.org/uniprot/CO1A1_HUMAN CO1A1_HUMAN] Type I collagen is a member of group I collagen (fibrillar forming collagen).
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 23: Line 24:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
 +
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Bertini, I]]
+
[[Category: Bertini I]]
-
[[Category: Fields, G B]]
+
[[Category: Fields GB]]
-
[[Category: Fragai, M]]
+
[[Category: Fragai M]]
-
[[Category: Lauer, J L]]
+
[[Category: Lauer JL]]
-
[[Category: Luchinat, C]]
+
[[Category: Luchinat C]]
-
[[Category: Melikian, M]]
+
[[Category: Melikian M]]
-
[[Category: Toccafondi, M]]
+
[[Category: Toccafondi M]]
-
[[Category: Contractile protein]]
+
-
[[Category: Structural protein]]
+
-
[[Category: Triple helical peptide]]
+

Revision as of 12:17, 15 November 2023

Solution structure of a THP type 1 alpha 1 collagen fragment (772-786)

PDB ID 2llp

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2llp"
Personal tools